FGA
CORZ icon

Fortis Group Advisors’s Core Scientific CORZ Stock Holding History

Fortis Group Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
10,645
+362
+4% +$8.52K 0.04% 229
2026
Q1 		$206K Buy
+10,283
New +$175K 0.03% 271

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Fortis Group Advisors's CORZ Position: Q2 2026 in Review

Fortis Group Advisors increased its Core Scientific (CORZ) stake by 3.5% in Q2 2026, buying an estimated $8.52K and bringing the position to 10,645 shares worth $272K. The position accounts for 0.04% of the portfolio, ranked #229.

Fortis Group Advisors first reported a position in CORZ in Q1 2026 and has held it in 2 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Fortis Group Advisors held 10,645 shares of Core Scientific worth $272K as of Q2 2026.
  • Fortis Group Advisors bought 362 Core Scientific shares in Q2 2026, an estimated $8.52K.
  • Core Scientific made up 0.04% of Fortis Group Advisors's portfolio in Q2 2026, its #229 holding.
  • Fortis Group Advisors first reported a position in Core Scientific in Q1 2026 and has held it in 2 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.